Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Keep an Eye on Synergy Pharma as Biotech Acquisitions Heat Up in 2011
Seeking Alpha
Sunday, January 30, 2011 - 12:02pm
tags:
SYNERGY, investors
Trading Idea - Is AstraZeneca close to Resistance?
Tradder's Huddle
Sunday, January 30, 2011 - 11:56am
tags:
AstraZeneca, investors
J&J Signed Remarkable Deal to extend the AIDS Drug Access
TopNews
Saturday, January 29, 2011 - 12:37pm
tags:
JNJ, AIDS
King Pharmaceuticals awards payment to Pain Therapeutics for abuse-resistant medications
News-Medical.net
Saturday, January 29, 2011 - 12:24pm
tags:
King, Pain Therapeutics, pain management
Biotech & Pharmaceutical Patenting Conference
Patent Docs
Saturday, January 29, 2011 - 12:14pm
tags:
patents
Sun Pharma Q3 PAT seen up 32% to Rs 446 cr
Money Control, India
Saturday, January 29, 2011 - 12:12pm
tags:
Sun Pharma
Zydus, Bayer Healthcare enter 50:50 venture
Business Standard
Saturday, January 29, 2011 - 11:59am
tags:
Bayer, Zydus Cadila
Angiotech To File For Bankruptcy
RTT News
Saturday, January 29, 2011 - 11:57am
tags:
Angiotech, bankruptcy
A Closer Look at ... Allergan, Merck, and Pfizer
Schaeffer's Investment Research
Saturday, January 29, 2011 - 11:56am
tags:
Allergan, Merck, Pfizer, investors
BiPar breast cancer drug fails late-stage trial
bizjournals.com
Saturday, January 29, 2011 - 11:55am
tags:
BiPar, breast cancer, iniparib
J&J Hip Replacement Plaintiff Committee Lawyers Named by Judge in Ohio
Bloomberg
Saturday, January 29, 2011 - 11:54am
tags:
JNJ, lawsuits
Looking Ahead at Bristol-Myers
Motley Fool
Saturday, January 29, 2011 - 11:53am
tags:
Bristol-Myers Squibb, investors
Avoid This Falling Knife for Now (Eli Lilly)
Motley Fool
Saturday, January 29, 2011 - 11:52am
tags:
Eli Lilly, investors
Celgene Needs a Rocket Ship
Motley Fool
Saturday, January 29, 2011 - 11:51am
tags:
Celgene, Abraxane
Pfizer Ordered to Pay $142.1 Million Over Neurontin `Off-Label' Marketing
Bloomberg
Saturday, January 29, 2011 - 11:49am
tags:
Pfizer, off label, Neurontin, settlements
Myriad Test May Pinpoint Tumor Drug Success After Sanofi Medicine Failed
Bloomberg
Saturday, January 29, 2011 - 11:48am
tags:
Myriad Genetics
Johnson & Johnson Told to Pay New Jersey Doctor $482 Million Over Patent
Bloomberg
Saturday, January 29, 2011 - 11:47am
tags:
JNJ, lawsuits
Endocyte plans to raise about $78 million in IPO
Yahoo/AP
Saturday, January 29, 2011 - 11:46am
tags:
Endocyte
A Busy Week For Novartis
Yahoo/CNBC
Saturday, January 29, 2011 - 11:45am
tags:
Novartis
Bionovo announces pricing of $30M offering
bizjournals.com
Saturday, January 29, 2011 - 11:44am
tags:
Bionovo

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.